We found that IVIG effectively ameliorated thrombocytopenia induced by all anti-GPIIbIIIa mAbs, but not anti-GPIbα mAbs (with the exception of the anti-GPIbα antibody p0p4) [135]. The gene discussed is GP1BA; the disease is Thrombocytopenia.